AJ-302

N/A

Report date: 2024/10/09 20:00:32
NME

Base Information

Drug NameAJ-302
Drug Alias NameAJ-302AJ302-IM
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAnnJi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnnJi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A